poisar

Stocks · News reference

Bernstein Upgrades Agilon Health to Outperform, Raises Price Target to $125

Benzinga Newsdesk

Bernstein analyst Lance Wilkes upgrades Agilon Health (NYSE:AGL) from Market Perform to Outperform and raises the price target from $86 to $125.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

AGL
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Delveinsight

    Global Value-Based Healthcare Market is Predicted to Cross USD 60 Billion by 2034 | DelveInsight

    The value-based healthcare market is experiencing robust growth, projected to reach USD 62 billion by 2034 from USD 16.5 billion in 2025, with a CAGR of ~16%. The shift from fee-for-service to outcome-based payment models is driven by rising healthcare costs, chronic disease burden, and government reimbursement reforms. North America dominates with 72% market share, while Asia-Pacific is expected to record the fastest growth. Key players include Optum, Humana, Evolent Health, Agilon Health, and Privia Health.

    UNHHUMEVHAGLPRVA